These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
648 related articles for article (PubMed ID: 16818032)
1. Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized study. Escribá MJ; Bellver J; Bosch E; Sánchez M; Pellicer A; Remohí J Fertil Steril; 2006 Jul; 86(1):92-7. PubMed ID: 16818032 [TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer. Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156 [TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized, controlled trial comparing three different gonadotropin regimens in oocyte donors: ovarian response, in vitro fertilization outcome, and analysis of cost minimization. Melo M; Bellver J; Garrido N; Meseguer M; Pellicer A; Remohí J Fertil Steril; 2010 Aug; 94(3):958-64. PubMed ID: 19931075 [TBL] [Abstract][Full Text] [Related]
4. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial. Serna J; Cholquevilque JL; Cela V; Martínez-Salazar J; Requena A; Garcia-Velasco JA Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847 [TBL] [Abstract][Full Text] [Related]
5. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study. Schachter M; Friedler S; Ron-El R; Zimmerman AL; Strassburger D; Bern O; Raziel A Fertil Steril; 2008 Oct; 90(4):1087-93. PubMed ID: 18023439 [TBL] [Abstract][Full Text] [Related]
6. The singleton, term gestation, and live birth rate per cycle initiated: a 1-year experience in in vitro fertilization cycles with native and donated oocytes. Bellver J; Albert C; Soares SR; Alvarez C; Pellicer A Fertil Steril; 2005 May; 83(5):1404-9. PubMed ID: 15866576 [TBL] [Abstract][Full Text] [Related]
7. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989 [TBL] [Abstract][Full Text] [Related]
8. In vivo maturation of oocytes by extending the interval between human chorionic gonadotropin administration and oocyte retrieval. Raziel A; Schachter M; Strassburger D; Kasterstein E; Ron-El R; Friedler S Fertil Steril; 2006 Sep; 86(3):583-7. PubMed ID: 16828475 [TBL] [Abstract][Full Text] [Related]
9. Phytoestrogens may improve the pregnancy rate in in vitro fertilization-embryo transfer cycles: a prospective, controlled, randomized trial. Unfer V; Casini ML; Gerli S; Costabile L; Mignosa M; Di Renzo GC Fertil Steril; 2004 Dec; 82(6):1509-13. PubMed ID: 15589851 [TBL] [Abstract][Full Text] [Related]
10. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer. Mui Lam P; Chun Cheung M; Ping Cheung L; Ingrid Lok H; John Haines C Gynecol Endocrinol; 2008 Dec; 24(12):674-80. PubMed ID: 19172535 [TBL] [Abstract][Full Text] [Related]
11. Efficiency of changing the embryo transfer time from day 3 to day 2 among women with poor ovarian response: a prospective randomized trial. Bahceci M; Ulug U; Ciray HN; Akman MA; Erden HF Fertil Steril; 2006 Jul; 86(1):81-5. PubMed ID: 16716322 [TBL] [Abstract][Full Text] [Related]
12. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial. Serafini P; Yadid I; Motta EL; Alegretti JR; Fioravanti J; Coslovsky M Fertil Steril; 2006 Oct; 86(4):830-8. PubMed ID: 16963040 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction. Kleinstein J; Fertil Steril; 2005 Jun; 83(6):1641-9. PubMed ID: 15950631 [TBL] [Abstract][Full Text] [Related]
14. Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of Menopur and Bravelle for controlled ovarian hyperstimulation. Doody KJ; Schnell VL; Foulk RA; Miller CE; Kolb BA; Blake EJ; Yankov VI Fertil Steril; 2009 Apr; 91(4):1012-7. PubMed ID: 18371963 [TBL] [Abstract][Full Text] [Related]
15. Comparison of starting ovarian stimulation on day 2 versus day 15 of the menstrual cycle in the same oocyte donor and pregnancy rates among the corresponding recipients of vitrified oocytes. Martínez F; Clua E; Devesa M; Rodríguez I; Arroyo G; González C; Solé M; Tur R; Coroleu B; Barri PN Fertil Steril; 2014 Nov; 102(5):1307-11. PubMed ID: 25154677 [TBL] [Abstract][Full Text] [Related]
16. Contrasting patterns in in vitro fertilization pregnancy rates among fresh autologous, fresh oocyte donor, and cryopreserved cycles with the use of day 5 or day 6 blastocysts may reflect differences in embryo-endometrium synchrony. Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R Fertil Steril; 2008 Jan; 89(1):20-6. PubMed ID: 17224151 [TBL] [Abstract][Full Text] [Related]
17. Effect of progesterone supplementation in early pregnancy on the pregnancy outcome after in vitro fertilization. Proctor A; Hurst BS; Marshburn PB; Matthews ML Fertil Steril; 2006 May; 85(5):1550-2. PubMed ID: 16603159 [TBL] [Abstract][Full Text] [Related]
18. Outcome of in vitro fertilization/intracytoplasmic sperm injection after laparoscopic cystectomy for endometriomas. Esinler I; Bozdag G; Aybar F; Bayar U; Yarali H Fertil Steril; 2006 Jun; 85(6):1730-5. PubMed ID: 16690058 [TBL] [Abstract][Full Text] [Related]
19. Transfer and uterine factors are the major recipient-related determinants of success with donor eggs. Zenke U; Chetkowski RJ Fertil Steril; 2004 Oct; 82(4):850-6. PubMed ID: 15482759 [TBL] [Abstract][Full Text] [Related]
20. The benefit of human chorionic gonadotropin supplementation throughout the secretory phase of frozen-thawed embryo transfer cycles. Ben-Meir A; Aboo-Dia M; Revel A; Eizenman E; Laufer N; Simon A Fertil Steril; 2010 Feb; 93(2):351-4. PubMed ID: 19342020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]